News

New Research Reveals Most Effective Obesity Drug: It’s Not Ozempic or Wegovy
A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...
Muscle-sparing obesity drug safe for Phase 3 trial, Veru says
The company is preparing a Phase 3 trial of enobosarm with a novel formulation that could extend its patent life.
Pfizer's Oral Obesity Drug Flop - A Symptom Of A Deeper Pipeline Problem
Pfizer halted its oral obesity drug, danuglipron, in April 2025 due to liver injury concerns, a major pipeline setback. Find ...
MedPage Today on MSN5d
RFK Jr. Threatens Publishing Ban; Obesity Drug Costs Fall; Nurses' Brain Tumor Probe
Kennedy Jr. threatened to bar NIH scientists from publishing in leading medical journals, saying the New England Journal of ...
Viking Therapeutics: Obesity Candidates Must Prove Their Edge As Market Matures (Upgrade)
Viking Therapeutics faces tough obesity drug rivals, with VK2735 showing promise but an uncertain edge. Find out why VKTX ...
Seattle weight loss patients fret over FDA limits on off-brand drugs
As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...
Wegovy discount: Price for weight-loss drug gets cut to $199, but there's a catch
Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of ...
FDA approves the first at-home cervical cancer test
The FDA has approved the first at-home cervical cancer test and weight loss drugs could reduce obesity related cancers. Neurosurgeon and scientist, Dr. Rahul Jandial, joined us with more details ...
Novo Nordisk is betting on a CEO shake-up to regain its weight loss drug edge over Eli Lilly
Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...